Naltrexone Hydrochloride/Clonidine Hydrochloride

盐酸纳曲酮/盐酸可乐定

Report date: 2023/07/28 20:00:50

Base Information

Drug NameNaltrexone Hydrochloride/Clonidine Hydrochloride
Drug Alias Name纳曲酮+可乐定Naltrexone+Clonidine可乐定+纳曲酮Naltrexone/Clonidine纳曲酮/可乐定 +[8] 
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors alpha-2 agonistsMu opioid receptor antagonists
TargetsAlpha-2c adrenergic receptorAlpha-2a adrenergic receptorAlpha-2b adrenergic receptor +[5] 
Therapy Area/IndicationsFacial PainLow Back PainRadiculopathy +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Naltrexone HydrochlorideClonidine Hydrochloride
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllodynic Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllodynic Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsFacial PainLow Back PainRadiculopathy +[5] 

Other Information

ATC CodeN/A
Related LinksN/A